pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
NEKTAR THERAPEUTICS ($NKTR) · news · pharmadog
← back to NEKTAR THERAPEUTICS
News mentioning $NKTR
8
stories
10d
Jury awards Nektar $90M in suit against Lilly
endpoints
10d
STAT+: Lilly wins approval for once-weekly insulin shot
stat
10d
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
biospace
10d
STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more
stat
10d
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
biopharma dive
Aug 11, 26
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
biopharma dive
Jul 13, 26
Q32 bounces back to claim study success for alopecia drug
biopharma dive
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
